| Name | Title | Contact Details |
|---|
SmartLinx enables companies to simplify the management of their human capital through industry-relevant, solutions. Our WorkLinx™ platform helps clients optimize workforce efficiency and productivity, comply with regulatory and licensing requirements, and avoid unnecessary labor expense, without compromising the quality of the products and services they deliver. A fusion of powerful capabilities within a single integrated solution, WorkLinx is leveraged by multiple industries. More than 2000 locations rely on SmartLinx solutions to manage, monitor and optimize their people resources and costs. Our suite includes staff schedule optimization, time & attendance, HR, payroll, employee self service, in-service licensing management, time clocks, and corporate planning & control. To ensure our clients success, we have best-in-class implementation, training and customer support services. Our implementation team has extensive human capital management solution experience and expertise, managed hundreds of implementations and uses a proven methodology, allowing for faster deployment. Our superior customer support team are product knowledge experts. They use a support management system to log, track and resolve issues quickly. To make the training as effective as possible, we use different types and methods to maintain the quality of training, ensuring our clients are successful in learning and using our system. Our vision is to become the global leader in human capital management solutions and to drive a new era in cost effectiveness, innovation, and simplicity.
Nextworld is ERP redefined. A cloud-based ERP software built on a no-code development platform. Learn how your company can benefit from cloud ERP!
Density measures how people use space in real-time without invading privacy. Using proprietary depth sensors and deep learning algorithms, the platform accurately and anonymously counts people in real time.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
At Shaw Trust we believe in fairness, equality and opportunity. We believe everyone has the right to live a decent and dignified life and an opportunity for rewarding work. We are a social purpose organisation challenging inequality and breaking down barriers to enable social mobility. Having grown from humble beginnings in 1982 in the village of Shaw in Wiltshire, finding jobs for disabled people, today we are a complex and diverse group committed to employment as the core pathway to a better life. We have grown through a combination of organic growth, mergers and acquisitions to be the UK`s largest Not-for-Profit (NFP) social enterprise in the employment sector. Empowering people from childhood to career our services embrace employability, education, learning and skills, children`s services and health and wellbeing support.